Azienda Unita' Sanitaria Locale Di Modena

Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial

Summary Venetoclax (VEN) plus hypomethylating agents (HMAs) represents the standard of care for newly diagnosed acute myeloid leukaemia (AML) patients unfit for intensive chemotherapy, but prospective real‐world observational data outside randomized clinical trials remain limited...

Gas-phase synthesis of plasmonic nanoparticles with robust high bandgap shell materials: A study of Cu@CaF2 with AI supported transmission electron microscopy analysis

Cu@CaF2 plasmonic nanoparticle (NP) films are physically synthesized, and their morphology, and electronic and optical properties are thoroughly investigated. Cu NPs are generated using a gas aggregation source assisted by magnetron sputtering, while CaF2 coatings are deposited b...

Real-world effectiveness of a multicomponent early intervention program for first episode psychosis in Emilia Romagna (Italy): Timeliness, specificity and fairness

Background This study provides a real-world evaluation of the multicomponent Emilia-Romagna First Episode Psychosis Program (RER-FEP) (2013–2019). It assesses how timeliness, treatment specificity, and socio-demographic factors related to fairness (including citizenship) are asso...